ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Electronics-Free Visual Monitoring of Dry Eye Disease-Related Tear Biomarkers Using Smart Scleral Lenses.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Dry eye disease (DED) is a prevalent ocular condition characterized by tear film instability, hyperosmolarity, inflammation, and neurosensory abnormalities. Its episodic and fluctuating nature complicates diagnosis and management, as conventional clinical assessments often fail to capture transient tear film changes. Although emerging tear-sensing technologies show promise, many rely on trained personnel, only sporadic measurements, external readers, or integrated electronics, limiting their practicality for in-eye applications. Here, we present an electronics-free scleral lens platform for wearable monitoring of DED-related tear biomarker changes using passive colorimetric sensors integrated within the lens tear reservoir. This configuration enables visual and smartphone-assisted readout of chloride ions, pH, and ocular surface temperature within physiologically relevant ranges while avoiding direct contact with the corneal surface. The vaulted scleral lens geometry forms a stable, self-replenishing tear reservoir that concentrates biomarkers while shielding sensors from corneal contact and eyelid pressure. Sensor color changes are directly observable and quantifiable via a smartphone without specialized readers or user-specific calibration. Validated using artificial tear fluids, human tear samples, and in vivo models, this platform enables wearable monitoring of DED-related biomarkers within physiologically relevant ranges, offering a simple and clinically viable approach for tracking ocular surface conditions and associated treatment efficacy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.